These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6185194)
1. Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx. Schuller DE; Wilson HE; Smith RE; Batley F; James AD Cancer; 1983 Jan; 51(1):15-9. PubMed ID: 6185194 [TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy in early-stage and locally advanced small bulk squamous cell carcinoma of the oral cavity and oropharynx. Tichler T; Ramon Y; Rath P; Hendler S; Brenner HJ Isr J Med Sci; 1988; 24(9-10):539-44. PubMed ID: 2462551 [TBL] [Abstract][Full Text] [Related]
4. [Antineoplastic chemotherapy of head and neck tumors (author's transl)]. Weidauer H HNO; 1981 Nov; 29(11):374-80. PubMed ID: 6171551 [TBL] [Abstract][Full Text] [Related]
5. [The remission of extensive cancers of the mouth and oropharynx with intra-arterial polychemotherapy with vincristine, methotrexate, bleomycin, cisplatin (VMBP)]. Mika H Laryngol Rhinol Otol (Stuttg); 1982 Sep; 61(9):520-3. PubMed ID: 6183545 [TBL] [Abstract][Full Text] [Related]
6. [Comparative study of 2 chemotherapy induction protocols. Cisplatinum-methotrexate-bleomycin and oncovin-methotrexate-bleomycin]. Laccourreye H; Beutter P; Brasnu D; Lacau-Saint-Guily J; Bassot V; Garabedian N; Jacquillat C Ann Otolaryngol Chir Cervicofac; 1983; 100(4):269-74. PubMed ID: 6192747 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy protocol for stage III or IV carcinoma of the oral cavity, oropharynx and hypopharynx. Schuller DE; King GW; Smith RE; Wilson HE; James AD; Batley F Laryngoscope; 1980 Aug; 90(8 Pt 1):1263-72. PubMed ID: 7401827 [TBL] [Abstract][Full Text] [Related]
8. [Cytostatic primary therapy of squamous cell carcinoma of the oro- and hypopharynx with cisplatin, bleomycin and methotrexate]. Deitmer T; Urbanitz D Laryngol Rhinol Otol (Stuttg); 1986 Jan; 65(1):7-10. PubMed ID: 2419720 [TBL] [Abstract][Full Text] [Related]
9. Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx. Damascelli B; Patelli G; Tichá V; Di Tolla G; Frigerio LF; Garbagnati F; Lanocita R; Marchianò A; Spreafico C; Mattavelli F; Bruno A; Zunino F J Vasc Interv Radiol; 2007 Nov; 18(11):1395-403. PubMed ID: 18003990 [TBL] [Abstract][Full Text] [Related]
10. Intravenous chemotherapy with syndronization in advanced cancer of oral cavity and oropharynx. Auersperg M; Soba E; Vraspir-Porenta O Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 Nov; 90(2):149-59. PubMed ID: 74141 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen. Elias EG; Chretien PB; Monnard E; Khan T; Bouchelle WH; Wiernik PH; Lipson SD; Hande KR; Zentai T Cancer; 1979 Mar; 43(3):1025-31. PubMed ID: 85477 [No Abstract] [Full Text] [Related]
12. Is surgery necessary in stage III and stage IV cancer of the head and neck that responds to induction chemotherapy? Poulsen M; Aldren C; Tripcony L; Walker Q Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):467-71. PubMed ID: 8615961 [TBL] [Abstract][Full Text] [Related]
13. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study. King GW; Halpin JJ; Smith RE; Batley F; Schuller DE Cancer Treat Rep; 1979; 63(11-12):1735-8. PubMed ID: 93508 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate and radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, oropharynx, supraglottic larynx, and hypopharynx. (Preliminary report of a controlled clinical trial of the Radiation Therapy Oncology Group). Kramer S Can J Otolaryngol; 1975; 4(2):213-8. PubMed ID: 1139418 [No Abstract] [Full Text] [Related]
15. Combination chemotherapy with cis-diamminedichloroplatinum, oncovin, and bleomycin (COB) in advanced head and neck cancer: phase II. Amer MH; Izbicki RM; Vaitkevicius VK; Al-Sarraf M Cancer; 1980 Jan; 45(2):217-23. PubMed ID: 6153149 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx. Fazekas JT; Sommer C; Kramer S Int J Radiat Oncol Biol Phys; 1980 May; 6(5):533-41. PubMed ID: 7410127 [No Abstract] [Full Text] [Related]
17. [Clinical and histopathological considerations on intra-arterial cisplatin therapy followed by surgery in the management of squamous cell carcinoma of the oral cavity and oropharynx]. Comoretto R; Grigoletto E; Delendi N; Quadu G; Barzan L; Frustaci S; Godeassi F; Tumolo S Acta Otorhinolaryngol Ital; 1983; 3(2):159-65. PubMed ID: 6683922 [No Abstract] [Full Text] [Related]
18. [Results of an interdisciplinary study of primary inoperable stage T3 and T4 squamous cell carcinoma of the mouth, oropharynx and hypopharynx]. Rohrmeier M; Langnickel R; Hilpert P HNO; 1987 Jan; 35(1):14-8. PubMed ID: 3558010 [TBL] [Abstract][Full Text] [Related]
19. Combined-modality treatment with induction chemotherapy in locally advanced squamous cell carcinoma of the oral cavity and oropharynx. Abele R; Lehmann W; Pipard G; Alberto P Recent Results Cancer Res; 1985; 98():142-7. PubMed ID: 4035070 [No Abstract] [Full Text] [Related]
20. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study. Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J Oncology; 2002; 63(4):338-45. PubMed ID: 12417788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]